MedPath

Validation of the SIB-Margin-Score

Conditions
C64
Malignant neoplasm of kidney, except renal pelvis
Registration Number
DRKS00010612
Lead Sponsor
Klinik für UrologieUniklinik Köln
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Ability to agree to the study
Kidney tumor with probability of organ sparing resection

Exclusion Criteria

under full age
Incapability of consent

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The validity of the SIB-Margin-Score is tested by histopathological criteria (thickness of parents layer on pseudo capsula)
Secondary Outcome Measures
NameTimeMethod
Interpersonal validity is tested by comparison of the results of different persons analyzing the resection technique.
© Copyright 2025. All Rights Reserved by MedPath